Freedom Capital Markets Starts AtriCure (ATRC) at Buy
Freedom Capital Markets analyst Keith Hinton initiates coverage on Articure (NASDAQ: ARTC) with a Buy rating and a price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
